Jared Moss, MD
Urology · Shreveport, LANPI 1548571185
Payments from drug & device makers
Across 392 payments — averaging $932.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Laborie Medical Technologies Corp.$344K
- Coloplast$15K
- Urotronic, Inc$4K
- Boston Scientific$440
- Endo Pharmaceuticals Inc.$263
- Pfizer$185
- plus $1K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Laborie Medical Technologies Corp. | 57 | $344,384 |
| Coloplast | 237 | $14,668 |
| Urotronic, Inc | 1 | $4,122 |
| Boston Scientific | 12 | $440 |
| Endo Pharmaceuticals Inc. | 13 | $263 |
| Pfizer | 14 | $185 |
| Medtronic(2 entities) | 4 | $173 |
| Astellas Pharma US Inc | 12 | $147 |
| Endo USA, Inc. | 8 | $144 |
| Cook Medical LLC | 2 | $108 |
| Koelis Inc. | 1 | $99 |
| Ferring Pharmaceuticals Inc. | 4 | $96 |
| AbbVie(2 entities) | 7 | $92 |
| Siemens Medical Solutions USA, Inc. | 1 | $66 |
| Blue Earth Diagnostics | 2 | $48 |
| Calyxo, Inc. | 2 | $48 |
| Teleflex LLC | 2 | $37 |
| AstraZeneca | 1 | $35 |
| Progenics Pharmaceuticals, Inc. | 1 | $30 |
| Travere Therapeutics, Inc. | 2 | $29 |
| Amgen | 1 | $22 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $21 |
| Galderma Laboratories, L.p. | 1 | $19 |
| Dendreon Pharmaceuticals LLC | 1 | $18 |
| Urogen Pharma, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Urovant Sciences Inc | 1 | $14 |
| Amniox Medical, Inc. | 1 | $14 |
| Tolmar, Inc. | 1 | $13 |
How this compares
$365,363 in reported general payments places this provider in the 95th percentile of 199 urology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Shreveport
- Ralph HendersonShreveport$4M
- Kevin ClineShreveport$1.3M
- Ashley BakerShreveport$705K
- James NobleShreveport$273K
- Jeremy NorwoodShreveport$128K
- Kevin HebertShreveport$54K
- Thomas PalmerShreveport$45K
- Nazih KhaterShreveport$23K
- David PriceShreveport$23K
- Tajammul FaziliShreveport$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.